3918

524816

NATCOPHARM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NATCO PHARMA LTD. Share Price Today

NATCO PHARMA LTD. is currently trading at ₹892.9, up by ₹8.6 from the previous close. The stock touched an intraday high of ₹913.40 and a low of ₹884.80 during the latest trading session. Over the past one year, NATCO PHARMA LTD. has delivered a return of 1.73%, while the stock has declined 24.39% in the last one month.

NATCO PHARMA LTD. performance

Today’s low Today’s high
₹ 884.80 ₹ 913.40
₹ 886.50
52 week low 52 week high
₹ 789.00 ₹ 1226.80
₹ 886.50
Open Price ₹ 893.10
Prev. Close ₹ 884.30
Volume (Shares) 768713.00
Total traded value ₹ 6814.64
Upper Circuit ₹ 1061.10
Lower Circuit ₹ 707.50
info

Investment Returns

Over 1 Month -24.39% Over 3 Months -4.66% Over 6 Months -4.28% Over 1 Year 1.73%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NATCO PHARMA LTD. fundamentals


  • Market cap (Cr) 15,924.70
  • P/E Ratio (TTM) 12.36
  • Beta 1.17
  • Book Value / share 477.50
  • Return on equity 28.63%
  • EPS (TTM) 71.55
  • Dividend yield 0.57%
  • Net profit/quarter (Cr) 209.60
info icon alternate text
  • Market cap (Cr) 15,947.00
  • P/E Ratio (TTM) 12.36
  • Beta 1.05
  • Book Value / share 477.50
  • Return on equity 28.63%
  • EPS (TTM) 71.55
  • Dividend yield 0.57%
  • Net profit/quarter (Cr) 209.60
info icon alternate text

NATCO PHARMA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 608.80
Operating Expense 571.70
Net Profit 209.60
Net Profit Margin (%) 34.42
Earnings Per Share (EPS) 11.70
EBITDA 165.30
Effective Tax Rate (%) -90.54
Particulars DEC 2025 (Values in Cr)
Revenue 528.80
Operating Expense 458.90
Net Profit 106.90
Net Profit Margin (%) 20.21
Earnings Per Share (EPS) 5.97
EBITDA 175.60
Effective Tax Rate (%) 14.61
Particulars SEP 2025 (Values in Cr)
Revenue 1264.30
Operating Expense 771.60
Net Profit 500.90
Net Profit Margin (%) 39.61
Earnings Per Share (EPS) 27.97
EBITDA 645.80
Effective Tax Rate (%) 14.52
Particulars JUN 2025 (Values in Cr)
Revenue 1192.70
Operating Expense 709.40
Net Profit 464.10
Net Profit Margin (%) 38.91
Earnings Per Share (EPS) 25.91
EBITDA 599.30
Effective Tax Rate (%) 14.51
Particulars MAR 2025 (Values in Cr)
Revenue 1157.40
Operating Expense 698.69
Net Profit 428.10
Net Profit Margin (%) 36.98
Earnings Per Share (EPS) 23.90
EBITDA 623.30
Effective Tax Rate (%) 17.79
Particulars MAR 2026 (Values in Cr)
Revenue 3594.60
Operating Expense 2511.60
Net Profit 1281.50
Net Profit Margin (%) 35.65
Earnings Per Share (EPS) 71.55
EBITDA 1585.99
Effective Tax Rate (%) 6.05
Particulars MAR 2025 (Values in Cr)
Revenue 4094.50
Operating Expense 2189.79
Net Profit 1850.40
Net Profit Margin (%) 45.19
Earnings Per Share (EPS) 103.31
EBITDA 2465.60
Effective Tax Rate (%) 16.87
Particulars MAR 2024 (Values in Cr)
Revenue 3568.90
Operating Expense 2118.30
Net Profit 1306.60
Net Profit Margin (%) 36.61
Earnings Per Share (EPS) 72.79
EBITDA 1741.70
Effective Tax Rate (%) 15.99
Particulars MAR 2023 (Values in Cr)
Revenue 2351.00
Operating Expense 1665.80
Net Profit 637.10
Net Profit Margin (%) 27.09
Earnings Per Share (EPS) 34.90
EBITDA 930.20
Effective Tax Rate (%) 17.33
Particulars MAR 2022 (Values in Cr)
Revenue 1767.80
Operating Expense 1706.50
Net Profit 139.10
Net Profit Margin (%) 7.86
Earnings Per Share (EPS) 7.63
EBITDA 307.60
Effective Tax Rate (%) 10.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 424.97
ROE % 27.98
ROCE % 32.48
Total Debt to Total Equity 0.05
EBITDA Margin 57.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 326.99
ROE % 25.88
ROCE % 29.63
Total Debt to Total Equity 0.05
EBITDA Margin 47.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 267.06
ROE % 15.66
ROCE % 17.70
Total Debt to Total Equity 0.06
EBITDA Margin 38.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 233.62
ROE % 3.28
ROCE % 3.82
Total Debt to Total Equity 0.08
EBITDA Margin 16.44
Particulars MAR 2021 (Values in Cr)
Book Value / Share 225.84
ROE % 11.21
ROCE % 13.68
Total Debt to Total Equity 0.07
EBITDA Margin 34.59
Particulars MAR 2025 (Values in Cr)
Book Value / Share 409.72
ROE % 28.63
ROCE % 32.75
Total Debt to Total Equity 0.05
EBITDA Margin 60.22
Particulars MAR 2024 (Values in Cr)
Book Value / Share 312.42
ROE % 25.38
ROCE % 28.58
Total Debt to Total Equity 0.05
EBITDA Margin 48.80
Particulars MAR 2023 (Values in Cr)
Book Value / Share 257.64
ROE % 14.33
ROCE % 16.17
Total Debt to Total Equity 0.06
EBITDA Margin 39.57
Particulars MAR 2022 (Values in Cr)
Book Value / Share 229.69
ROE % 2.54
ROCE % 2.77
Total Debt to Total Equity 0.08
EBITDA Margin 14.98
Particulars MAR 2021 (Values in Cr)
Book Value / Share 224.17
ROE % 7.78
ROCE % 9.25
Total Debt to Total Equity 0.07
EBITDA Margin 31.37
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2176.00
Total Assets 8630.80
Total Liabilities 8630.80
Total Equity 7612.30
Share Outstanding 17
Price to Book Ratio 1.95
Return on Assets (%) 21.84
Return on Capital (%) 23.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 952.90
Total Assets 6906.30
Total Liabilities 6906.30
Total Equity 5853.10
Share Outstanding 17
Price to Book Ratio 3.05
Return on Assets (%) 20.10
Return on Capital (%) 22.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 546.30
Total Assets 5657.40
Total Liabilities 5657.40
Total Equity 4873.80
Share Outstanding 18
Price to Book Ratio 2.19
Return on Assets (%) 12.64
Return on Capital (%) 14.2
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 206.10
Total Assets 5109.10
Total Liabilities 5109.10
Total Equity 4263.60
Share Outstanding 18
Price to Book Ratio 3.30
Return on Assets (%) 3.32
Return on Capital (%) 3.64
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 283.50
Total Assets 4791.90
Total Liabilities 4791.90
Total Equity 4123.40
Share Outstanding 18
Price to Book Ratio 3.68
Return on Assets (%) 9.20
Return on Capital (%) 10.04
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1856.90
Total Assets 8269.90
Total Liabilities 8269.90
Total Equity 7333.90
Share Outstanding 17
Price to Book Ratio 1.95
Return on Assets (%) 22.37
Return on Capital (%) 24.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 864.90
Total Assets 6554.00
Total Liabilities 6554.00
Total Equity 5592.30
Share Outstanding 17
Price to Book Ratio 3.05
Return on Assets (%) 19.93
Return on Capital (%) 21.94
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 412.00
Total Assets 5387.90
Total Liabilities 5387.90
Total Equity 4702.00
Share Outstanding 18
Price to Book Ratio 2.19
Return on Assets (%) 11.82
Return on Capital (%) 13.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 100.90
Total Assets 4978.00
Total Liabilities 4978.00
Total Equity 4191.90
Share Outstanding 18
Price to Book Ratio 3.30
Return on Assets (%) 2.79
Return on Capital (%) 3.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 262.80
Total Assets 4752.50
Total Liabilities 4752.50
Total Equity 4091.10
Share Outstanding 18
Price to Book Ratio 3.68
Return on Assets (%) 6.51
Return on Capital (%) 7.12
Particulars MAR 2025 (Values in Cr)
Net Income 2291.40
Cash from Operations 2069.40
Cash from Investing -1414.50
Cash from Financing -210.70
Net change in Cash 71.60
Free Cash Flow 2470.50
Particulars MAR 2024 (Values in Cr)
Net Income 1673.50
Cash from Operations 1497.90
Cash from Investing -1032.70
Cash from Financing -246.90
Net change in Cash -68.00
Free Cash Flow 1837.30
Particulars MAR 2023 (Values in Cr)
Net Income 861.90
Cash from Operations 1026.60
Cash from Investing -477.10
Cash from Financing -363.00
Net change in Cash 9.00
Free Cash Flow 1172.89
Particulars MAR 2022 (Values in Cr)
Net Income 202.20
Cash from Operations 94.70
Cash from Investing -5.30
Cash from Financing 34.80
Net change in Cash 76.00
Free Cash Flow 327.50
Particulars MAR 2021 (Values in Cr)
Net Income 579.60
Cash from Operations 428.80
Cash from Investing -103.30
Cash from Financing -185.70
Net change in Cash 9.80
Free Cash Flow 683.40
Particulars MAR 2025 (Values in Cr)
Net Income 2226.00
Cash from Operations 2006.60
Cash from Investing -1443.90
Cash from Financing -212.40
Net change in Cash 5.70
Free Cash Flow 2410.29
Particulars MAR 2024 (Values in Cr)
Net Income 1555.30
Cash from Operations 1448.40
Cash from Investing -960.50
Cash from Financing -237.30
Net change in Cash -1.40
Free Cash Flow 1782.60
Particulars MAR 2023 (Values in Cr)
Net Income 770.70
Cash from Operations 932.80
Cash from Investing -436.60
Cash from Financing -346.80
Net change in Cash 1.00
Free Cash Flow 1075.30
Particulars MAR 2022 (Values in Cr)
Net Income 155.90
Cash from Operations 90.20
Cash from Investing -92.50
Cash from Financing 35.60
Net change in Cash 0.80
Free Cash Flow 315.70
Particulars MAR 2021 (Values in Cr)
Net Income 392.20
Cash from Operations 260.40
Cash from Investing -3.20
Cash from Financing -183.10
Net change in Cash -2.80
Free Cash Flow 500.29
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 13.06 1.52 242.16 23.12 38.85
BLISS GVS PHARMA LTD. 473.30 38.42 4.20 5019.64 118.35 493.70
CIPLA LTD 1415.30 30.04 3.32 114334.35 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.80 15.08 2.47 1005.95 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 22.10 4.07 242.16 23.12 38.85
AMRUTAJAN HEALTH LTD 546.80 24.51 4.26 1580.83 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8556.55 111.75 24.50 21391.38 7630.00 9850.00
BLISS GVS PHARMA LTD. 473.30 51.06 4.34 5019.64 118.35 493.70

NATCO PHARMA LTD. shareholding pattern

Holding
27.75%
49.41%
17.37%
5.45%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

NATCO PHARMA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
889.10 0.54 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 878.30
  • 26 Days 952.30
  • 10 Days 885.90
  • 50 Days 991.20
  • 12 Days 893.90
  • 100 Days 986.10
  • 20 Days 930.50
  • 200 Days 974.00
885.83 PIVOT
First Support 878.87 First Resistance 891.27 Second Support 873.43 Second Resistance 898.23 Third Support 866.47 Third Resistance 903.67
RSI 34.98 ADX 61.95 MACD -58.39 Williams % R -56.23 Commodity Channel Index (CCI) -41.69
Date 2026-06-22 Week 345125.00 Same Day 155715.00 Month 378013.00
1 Year 1.17 3 Year 0.88
Over 1 Month
-24.39% down
Over 1 Year
1.73% down
Over 3 Months
-4.66% down
Over 3 Years
12.14% down
Over 6 Months
-4.28% down
Over 5 Years
-4.05% down

NATCO PHARMA LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Feb 2026 1.5 Interim 3 18 Feb 2026 Equity shares
20 Nov 2025 1.5 Interim 2 20 Nov 2025 Equity shares
19 Aug 2025 2.0 Interim 1 19 Aug 2025 Equity shares
18 Feb 2025 1.5 Interim 3 18 Feb 2025 Equity shares
27 Nov 2024 1.5 Interim 2 27 Nov 2024 Equity shares
23 Aug 2024 3.0 Interim 23 Aug 2024 Equity shares
26 Feb 2024 1.25 Interim 3 26 Feb 2024 Equity shares
24 Nov 2023 1.25 Interim 2 24 Nov 2023 Equity shares
22 Aug 2023 7.0 Interim 22 Aug 2023 Equity shares
21 Feb 2023 1.25 Interim 3 21 Feb 2023 Equity shares
21 Nov 2022 0.75 Interim 2 22 Nov 2022 Equity shares
19 Aug 2022 3.5 Interim 22 Aug 2022 Equity shares
24 Feb 2022 2.0 Interim 3 25 Feb 2022 Equity shares
23 Nov 2021 0.5 Interim 2 24 Nov 2021 Equity shares
24 Aug 2021 2.0 Interim 25 Aug 2021 Equity shares
22 Feb 2021 1.0 Interim 3 23 Feb 2021 Equity shares
24 Nov 2020 3.0 Interim 2 25 Nov 2020 Equity shares
21 Aug 2020 1.25 Interim 24 Aug 2020 Equity shares
26 Jun 2020 1.0 Interim 4 29 Jun 2020 Equity shares
24 Feb 2020 3.5 Interim 3 25 Feb 2020 Equity shares
21 Nov 2019 1.0 Interim 2 22 Nov 2019 Equity shares
22 Aug 2019 1.25 Interim 23 Aug 2019 Equity shares
06 Jun 2019 1.25 Interim 3 07 Jun 2019 Equity shares
21 Feb 2019 3.5 Interim 2 22 Feb 2019 Equity shares
20 Aug 2018 1.5 Interim 21 Aug 2018 Equity shares
15 Feb 2018 7.0 Interim 2 17 Feb 2018 Equity shares
16 Aug 2017 1.25 Interim 18 Aug 2017 Equity shares
23 Feb 2017 6.0 Interim 2 27 Feb 2017 Equity shares
19 Aug 2016 0.75 Interim 22 Aug 2016 Equity shares
22 Feb 2016 1.25 Interim 23 Feb 2016 Equity shares
24 Feb 2015 5.0 Interim 25 Feb 2015 Equity shares
24 Feb 2014 5.0 Interim 25 Feb 2014 Equity shares
22 Feb 2013 4.0 Interim 25 Feb 2013 Equity shares
22 Feb 2012 3.0 Interim 23 Feb 2012 Equity shares
24 Feb 2011 2.0 Interim 25 Feb 2011 Equity shares
05 Feb 2010 2.0 Interim 08 Feb 2010 Equity shares
04 Jun 2009 1.25 Interim 05 Jun 2009 Equity shares
12 Nov 2007 1.25 Interim 13 Nov 2007 Equity shares
10 Nov 2006 1.25 Final 13 Nov 2006 Equity shares
10 Nov 2006 0.0 Interim 01 Jan 0001 Equity shares
Ex-Date Old FV NEW FV Record Date
26 Nov 2015 10.0 2.0 28 Nov 2015
Dividend date Dividend amount Dividend type Record date Instrument type
18 Feb 2026 1.5 Interim 3 18 Feb 2026 Equity shares
20 Nov 2025 1.5 Interim 2 20 Nov 2025 Equity shares
19 Aug 2025 2.0 Interim 1 19 Aug 2025 Equity shares
18 Feb 2025 1.5 Interim 3 18 Feb 2025 Equity shares
27 Nov 2024 1.5 Interim 2 27 Nov 2024 Equity shares
23 Aug 2024 3.0 Interim 23 Aug 2024 Equity shares
26 Feb 2024 1.25 Interim 3 26 Feb 2024 Equity shares
24 Nov 2023 1.25 Interim 2 24 Nov 2023 Equity shares
22 Aug 2023 7.0 Interim 22 Aug 2023 Equity shares
21 Feb 2023 1.25 Interim 3 21 Feb 2023 Equity shares
21 Nov 2022 0.75 Interim 2 22 Nov 2022 Equity shares
19 Aug 2022 3.5 Interim 22 Aug 2022 Equity shares
24 Feb 2022 2.0 Interim 3 25 Feb 2022 Equity shares
23 Nov 2021 0.5 Interim 2 24 Nov 2021 Equity shares
24 Aug 2021 2.0 Interim 25 Aug 2021 Equity shares
22 Feb 2021 1.0 Interim 3 23 Feb 2021 Equity shares
24 Nov 2020 3.0 Interim 2 25 Nov 2020 Equity shares
21 Aug 2020 1.25 Interim 24 Aug 2020 Equity shares
26 Jun 2020 1.0 Interim 4 29 Jun 2020 Equity shares
24 Feb 2020 3.5 Interim 3 25 Feb 2020 Equity shares
21 Nov 2019 1.0 Interim 2 22 Nov 2019 Equity shares
22 Aug 2019 1.25 Interim 23 Aug 2019 Equity shares
06 Jun 2019 1.25 Interim 3 07 Jun 2019 Equity shares
21 Feb 2019 3.5 Interim 2 22 Feb 2019 Equity shares
20 Aug 2018 1.5 Interim 21 Aug 2018 Equity shares
15 Feb 2018 7.0 Interim 2 17 Feb 2018 Equity shares
16 Aug 2017 1.25 Interim 18 Aug 2017 Equity shares
23 Feb 2017 6.0 Interim 2 27 Feb 2017 Equity shares
19 Aug 2016 0.75 Interim 22 Aug 2016 Equity shares
22 Feb 2016 1.25 Interim 23 Feb 2016 Equity shares
24 Feb 2015 5.0 Interim 25 Feb 2015 Equity shares
24 Feb 2014 5.0 Interim 25 Feb 2014 Equity shares
22 Feb 2013 4.0 Interim 25 Feb 2013 Equity shares
22 Feb 2012 3.0 Interim 23 Feb 2012 Equity shares
24 Feb 2011 2.0 Interim 25 Feb 2011 Equity shares
05 Feb 2010 2.0 Interim 08 Feb 2010 Equity shares
04 Jun 2009 1.25 Interim 05 Jun 2009 Equity shares
12 Nov 2007 1.25 Interim 13 Nov 2007 Equity shares
10 Nov 2006 1.25 Final 13 Nov 2006 Equity shares
10 Nov 2006 0.0 Interim 01 Jan 0001 Equity shares
Ex-Date Old FV NEW FV Record Date
26 Nov 2015 10.0 2.0 28 Nov 2015

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Natco Pharma Ltd?

Answer Field

Natco Pharma Ltd share price is for NSE ₹ 892.90 & for BSE ₹ 894.65 as on Jun 23 2026 03:30 PM.

What is the Market Cap of Natco Pharma Ltd Share?

Answer Field

The market cap of Natco Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 23 2026 03:30 PM.

What is the 52 Week High and Low of Natco Pharma Ltd?

Answer Field

The 52 Week High and Low of Natco Pharma Ltd for NSE is ₹ 1,226.80 and ₹ 789.00 and for BSE is ₹ 1,226.10 and ₹ 789.30.

What is 1 year return for Natco Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 1.73%.

What is the P/E Ratio of Natco Pharma Ltd Share?

Answer Field

As on Jun 23 2026 03:30 PM the price-to-earnings (PE) ratio for Natco Pharma Ltd share is 12.36.

What is the PB ratio of Natco Pharma Ltd Share?

Answer Field

As on Jun 23 2026 03:30 PM, the price-to-book (PB) ratio for Natco Pharma Ltd share is 477.50.

How to Buy Natco Pharma Ltd Share?

Answer Field

You can trade in Natco Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Natco Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Natco Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Natco Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|